A lawsuit against Bloomberg for issuing an erroneous headline has zero chance of succeeding, IMO. Egregious errors by Bloomberg, Reuters, DJ, AP, and other newswire services are astonishingly common because there’s competitive pressure to be first and the biotech writers and editors employed by the newswires don’t really know much about the subject.